Bookmark

Add to MyYahoo RSS

Angioedema News

News on Angioedema continually updated from thousands of sources around the net.

May 27, 2014 | Theflyonthewall.com

BioCryst data has favorable read through for Dyax, says Jefferies

On The Fly: Closing Wrap Stocks on Wall Street were higher as investors returned from their holiday weekend.

Comment?

Related Topix: Biotech, BioCryst Pharmaceuticals, Medicine, Healthcare Industry, Financial Markets, Health, Law, Healthcare Law

Fri May 16, 2014

Medical News Today

A safe and effective treatment for life-threatening angioedema attacks in the emergency department

In angioedema , patients experience a rapid swelling of the skin and subcutaneous tissues - which, in some cases, can lead to airway obstruction and suffocation.

Comment?

Related Topix: Medicine, Health, Heart Failure, Emergency Medicine

Fri Mar 14, 2014

The Motley Fool

Why Dyax Corp. Shares Dipped

So what: According to Dyax's press release this morning, it has filed to sell 8 million shares of common stock at $9.25 per share, an 8.9% discount to yesterday's closing price.

Comment?

Related Topix: Medicine, Health

Tue Mar 04, 2014

Seeking Alpha

New Sources Of Revenue And Profitability Are In The Future For Dyax

Biotech companies are intriguing as possible investments not only for their potential stock gains, but also for their contributions to help improve and save the lives of individuals.

Comment?

Related Topix: Biotech, Medicine, Dyax, Healthcare Industry, Health, Healthcare Law, Law

Sun Feb 23, 2014

Reuters

BRIEF-Pharming and Salix say FDA extended PDUFA date for angioedema drug Ruconest

If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links.

Comment?

Related Topix: Medicine, Health

•••
•••
•••
•••
•••
•••
•••
•••